Evaluation of four commercial COVID-19 diagnostic RT-PCR kits used in Libya
Article Sidebar
Main Article Content
Abstract
Background: Real-time reverse transcriptase chain reaction is considered the most sensitive and specific assay for COVID-19 detection. This study was planned to compare and evaluate four commercially diagnostic kits. Material and methods: 92 Nasopharyngeal swabs collected from different symptomatic patients were studied in this project. The total nucleic acid (RNA) was extracted, and RT-PCR was done using four commercial diagnostic kits from different manufacturers, DANN and BGI (China), Hibrigen, and Bio-speedy (Turkey). Result: Although all 92 clinical samples were subjected to the same four diagnostic kits, the results revealed variations in the performance. The total number of positive cases was (42/92) for Da An Gene, BGI (36/92), Bio-speedy (31/92), and Hibrirgen (14/92).
Downloads
Article Details
In a brief statement, the rights relate to the publication and distribution of research published in the journal of the Sebha University, where authors who have published their articles in the Sebha University journal can use or distribute their articles. They reserve all their rights to the published works, such as (but not limited to) the following rights:
- Copyright and other property rights related to the article, such as patent rights.
- Research published in the journal of the University of Sebha and used in its future works, including lectures and books, the right to reproduce articles for their own purposes, and the right to self-archive their articles.
- The right to enter a separate article, or for a non-exclusive distribution of their article with an acknowledgment of its initial publication in the journal of Sebha University.
- Privacy Statement The names and e-mail addresses entered on the Sebha University Journal site will be used for the aforementioned purposes only and for which they were used.
